TY - JOUR
T1 - Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals
AU - Álvarez, Cristina
AU - Andreu, Montserrat
AU - Castells, Antoni
AU - Quintero, Enrique
AU - Bujanda, Luis
AU - Cubiella, Joaquín
AU - Salas, Dolores
AU - Lanas, Ángel
AU - Carballo, Fernando
AU - Morillas, Juan Diego
AU - Hernández, Cristina
AU - Jover, Rodrigo
AU - Sarasqueta, Cristina
AU - Enriquéz-Navascués, José M.
AU - Hernández, Vicent
AU - Estévez, Pamela
AU - Macenlle, Ramiro
AU - Sala, Teresa
AU - Balaguer, Francesc
AU - Pellisé, Maria
AU - Moreira, Leticia
AU - Gil, Inés
AU - Peris, Antonio
AU - González-Rubio, Francisca
AU - Ferrández, Ángel
AU - Poves, Carmen
AU - Ponce, Marta
AU - Grau, Jaume
AU - Serradesanferm, Anna
AU - Ono, Akiko
AU - Cruzado, José
AU - Pérez-Riquelme, Francisco
AU - Alonso-Abreu, Inmaculada
AU - Carrillo-Palau, Marta
AU - Santander, Cecilio
AU - Díaz Tasende, José
AU - Herreros, Alberto
AU - Cacho, Guillermo
AU - Barranco, Luis Eugenio
AU - Bessa, Xavier
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Background: Serrated cancers account for 10% to 20% of all colorectal cancers (CRC) and more than 30% of interval cancers. The presence of proximal serrated polyps and large (≥10 mm) serrated polyps (LSP) has been correlated with colorectal neoplasia. Objective: To evaluate the prevalence of serrated polyps and their association with synchronous advanced neoplasia in a cohort of average-risk population and to assess the efficacy of one-time colonoscopy and a biennial fecal immunochemical test for reducing CRC-related mortality. This study focused on the sample of 5059 individuals belonging to the colonoscopy arm. Design: Multicenter, randomized, controlled trial. Setting: The ColonPrev study, a population-based, multicenter, nationwide, randomized, controlled trial. Patients: A total of 5059 asymptomatic men and women aged 50 to 69 years. Intervention: Colonoscopy. Main Outcome Measurements: Prevalence of serrated polyps and their association with synchronous advanced neoplasia. Results: Advanced neoplasia was detected in 520 individuals (10.3%) (CRC was detected in 27 [0.5%] and advanced adenomas in 493 [9.7%]). Serrated polyps were found in 1054 individuals (20.8%). A total of 329 individuals (6.5%) had proximal serrated polyps, and 90 (1.8%) had LSPs. Proximal serrated polyps or LSPs were associated with male sex (odds ratio [OR] 2.08, 95% confidence interval [CI], 1.76-4.45 and OR 1.65, 95% CI, 1.31-2.07, respectively). Also, LSPs were associated with advanced neoplasia (OR 2.49, 95% CI, 1.47-4.198), regardless of their proximal (OR 4.15, 95% CI, 1.69-10.15) or distal (OR 2.61, 95% CI, 1.48-4.58) locations. When we analyzed subtypes of serrated polyps, proximal hyperplasic polyps were related to advanced neoplasia (OR 1.61, 95% CI, 1.13-2.28), although no correlation with the location of the advanced neoplasia was observed. Limitations: Pathology criteria for the diagnosis of serrated polyps were not centrally reviewed. The morphology of the hyperplasic polyps (protruded or flat) was not recorded. Finally, because of the characteristics of a population-based study carried out in average-risk patients, the proportion of patients with CRC was relatively small. Conclusion: LSPs, but not proximal serrated polyps, are associated with the presence of synchronous advanced neoplasia. Further studies are needed to determine the risk of proximal hyperplastic polyps.
AB - Background: Serrated cancers account for 10% to 20% of all colorectal cancers (CRC) and more than 30% of interval cancers. The presence of proximal serrated polyps and large (≥10 mm) serrated polyps (LSP) has been correlated with colorectal neoplasia. Objective: To evaluate the prevalence of serrated polyps and their association with synchronous advanced neoplasia in a cohort of average-risk population and to assess the efficacy of one-time colonoscopy and a biennial fecal immunochemical test for reducing CRC-related mortality. This study focused on the sample of 5059 individuals belonging to the colonoscopy arm. Design: Multicenter, randomized, controlled trial. Setting: The ColonPrev study, a population-based, multicenter, nationwide, randomized, controlled trial. Patients: A total of 5059 asymptomatic men and women aged 50 to 69 years. Intervention: Colonoscopy. Main Outcome Measurements: Prevalence of serrated polyps and their association with synchronous advanced neoplasia. Results: Advanced neoplasia was detected in 520 individuals (10.3%) (CRC was detected in 27 [0.5%] and advanced adenomas in 493 [9.7%]). Serrated polyps were found in 1054 individuals (20.8%). A total of 329 individuals (6.5%) had proximal serrated polyps, and 90 (1.8%) had LSPs. Proximal serrated polyps or LSPs were associated with male sex (odds ratio [OR] 2.08, 95% confidence interval [CI], 1.76-4.45 and OR 1.65, 95% CI, 1.31-2.07, respectively). Also, LSPs were associated with advanced neoplasia (OR 2.49, 95% CI, 1.47-4.198), regardless of their proximal (OR 4.15, 95% CI, 1.69-10.15) or distal (OR 2.61, 95% CI, 1.48-4.58) locations. When we analyzed subtypes of serrated polyps, proximal hyperplasic polyps were related to advanced neoplasia (OR 1.61, 95% CI, 1.13-2.28), although no correlation with the location of the advanced neoplasia was observed. Limitations: Pathology criteria for the diagnosis of serrated polyps were not centrally reviewed. The morphology of the hyperplasic polyps (protruded or flat) was not recorded. Finally, because of the characteristics of a population-based study carried out in average-risk patients, the proportion of patients with CRC was relatively small. Conclusion: LSPs, but not proximal serrated polyps, are associated with the presence of synchronous advanced neoplasia. Further studies are needed to determine the risk of proximal hyperplastic polyps.
KW - CIMP
KW - colorectal cancer
KW - CpG island methylation phenotype
KW - CRC
KW - high degree of microsatellite instability
KW - HP
KW - hyperplastic polyp
KW - large serrated polyp
KW - LSP
KW - MSI-H
KW - sessile serrated adenoma
KW - SSA
KW - traditional serrated adenoma
KW - TSA
U2 - 10.1016/j.gie.2013.03.003
DO - 10.1016/j.gie.2013.03.003
M3 - Article
SN - 0016-5107
VL - 78
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 2
ER -